Lv7
3950 积分 2022-05-23 加入
Rethinking the role of synergy calculations in the next century of drug combination discovery
5天前
已完结
Pancreatic cancer
6天前
已完结
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
7天前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
7天前
已完结
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review
10天前
已完结
Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development
10天前
已完结
Model‐Informed Drug Development Approaches to Assist New Drug Development in the COVID‐19 Pandemic
10天前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
13天前
已完结
Perioperative approaches for patients with biliary tract cancer
13天前
已完结
Human and financial consequences of herding in oncology drug development: clinical trials of TIGIT inhibitors
17天前
已完结
皖公网安备34019202002308
